MedPath

Results of Cold Stored Allografts in Vascular Access

Completed
Conditions
End Stage Renal Failure on Dialysis
Hemodialysis Access Failure
Interventions
Procedure: Vascular access by pass using a cold stored venous allograft
Registration Number
NCT04446546
Lead Sponsor
Central Hospital, Nancy, France
Brief Summary

Vascular access creation in patients with renal failure requiring long-term hemodialysis can be a challenge when there is no more autologous material or in case of infection, in a population undergoing long term dialysis with a longer life-expectancy. Many types of grafts have been used, with its advantages and drawbacks, such as prosthetic grafts (PTFE). Over the past decade, surgeons have used cold stored venous allografts as a biological conduit for hemodialysis, with the idea of avoiding most of major complications including a lower incidence of infection and steal syndrome, with patencies at least equivalent to PTFE. There is only a few data in the litterature, but many surgical teams use it when there is no autologous material or in case of infection.

The aim of the study is to give the primary patency of vascular access with this technique, and to assess its long term outcomes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • End stage renal failure patient requiring hemodialysis
  • With the placement of a venous allograft for a hemodialysis approach
  • Who underwent a surgery between January 1, 2014 and December 31, 2018 in a vascular surgery department participating in our study
Exclusion Criteria
  • Patient <18 years old, or under guardianship / curatorship
  • Patient objecting to the use of his personal data in the context of research

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Cold Stored Allograft Vascular AccessVascular access by pass using a cold stored venous allograft-
Primary Outcome Measures
NameTimeMethod
Intervention free vascular access survival (in days)3 years

The interval in days between the vascular access creation and the first successful re intervention (primary patency)

Secondary Outcome Measures
NameTimeMethod
Thrombosis free vascular access survival (in days)3 years

The interval in days between the vascular access creation and the first occlusion with a successful re intervention (primary assisted pantency)

Abandonment of the vascular access (in days)3 years

The interval in days between the vascular access creation and its abandonment (secondary patency)

Trial Locations

Locations (1)

Departement of Vascular Surgery Nancy University Hospital

🇫🇷

Nancy, Lorraine, France

© Copyright 2025. All Rights Reserved by MedPath